Arlene Morris's Net Worth

$9.88 Million

Estimate Recalculated Nov 1, 2024 09:23AM EST

Who is Arlene Morris?

Arlene Morris has an estimated net worth of $9.88 Million. This is based on reported shares across multiple companies, which include Viridian Therapeutics, Inc.\DE, Biodel Inc, Cogent Biosciences, Inc., PALATIN TECHNOLOGIES INC, Dimension Therapeutics, Inc., MEDICINOVA INC, VIVEVE MEDICAL, INC., AFFYMAX INC, and Edgewise Therapeutics, Inc..

SEC CIK

Arlene Morris's CIK is 0001362520

Past Insider Trading and Trends

2010 was Arlene Morris's most active year for acquiring shares with 13 total transactions. Arlene Morris's most active month to acquire stocks was the month of May. 2007 was Arlene Morris's most active year for disposing of shares, totalling 153 transactions. Arlene Morris's most active month to dispose stocks was the month of August. 2010 saw Arlene Morris paying a total of $1,065,587.78 for 499,606 shares, this is the most they've acquired in one year. In 2009 Arlene Morris cashed out on 215,310 shares for a total of $2,691,425.55, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Viridian Therapeutics, Inc.\DE (VRDN) Snapshot price: $14.09

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 26
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Jun 3
Form 4
—
0
—
—
0
Feb 4
Form 4
—
0
—
—
0
May 21
Form 4
—
0
—
—
0
Jun 19
Form 4
—
0
—
—
0
Jun 27
Form 3
—
0
—
—
0
No matching records found

Biodel Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 24
Form 4
—
0
—
—
0
May 15
Form 3
—
0
—
—
0
No matching records found

Cogent Biosciences, Inc. (COGT) Snapshot price: $10.47

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 5
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Mar 11
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jul 26
Form 3
—
0
—
—
0
No matching records found

PALATIN TECHNOLOGIES INC (PTN) Snapshot price: $1.48

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+40.57%
12K
—
—
41.58K
Jul 15 - Jul 15
Form 4
+28.50%
10K
—
—
45.09K
Jun 20
Form 4
+8.79%
73K
—
—
903.67K
Jun 22
Form 4/A
+4.96%
33K
$0.62
$20,460.00
698.67K
Jul 1
Form 4
+4.96%
33K
$0.62
$20,460.00
698.67K
Jul 1
Form 4
+13.08%
77K
—
—
665.67K
Jun 22
Form 4
+19.59%
73K
—
—
445.58K
Jun 16
Form 4
+10.55%
32K
—
—
335.33K
Jun 24
Form 4
+4.33%
12K
$0.69
$8,223.32
289K
Nov 20
Form 4
+11.41%
28K
—
—
273.33K
Jun 26
Form 4
+18.02%
30K
—
—
196.5K
Dec 12
Form 4
+41.70%
54K
—
—
183.5K
Jun 20
Form 4
+248.65%
57.5K
—
—
80.63K
Jun 9 - Jun 13
Form 4
+171.44%
20K
—
—
31.67K
Dec 8
Form 4
—
0
—
—
0
Jun 11
Form 3
—
0
—
—
0
No matching records found

Dimension Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Nov 7
Form 4
—
0
—
—
0
May 25
Form 4
—
0
—
—
0
May 19
Form 3
—
0
—
—
0
No matching records found